Biopharma Temperature Controlled Logistics Approaches $13 Billion Globally

sourcebook_fig1_MA16

Source: Pharmaceutical Commerce

Preliminary data from Pharmaceutical Commerce’s annual Biopharma Cold Chain Sourcebook shows that managing the transportation of temperature-controlled products (refrigerated and frozen) will total $12.6 billion this year, continuing an 8–9%/yr growth rate that is roughly double that of pharma products overall (Fig. 1). The report, now in its seventh edition, pegs non-cold-chain pharma logistics costs at $78.8 billion and rising at the 4–5% growth rate of pharma volumes. By 2020, pharma cold-chain logistics will be worth $16.7 billion, and non-cold chain at $77.1 billion.

Click here for the full article.